Literature DB >> 17194712

Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction.

Sohail Q Khan1, Dominic Kelly, Paulene Quinn, Joan E Davies, Leong L Ng.   

Abstract

BACKGROUND: Inflammation plays a critical role in acute myocardial infarction (MI). One such inflammatory marker is myeloperoxidase (MPO). Its role as a predictor of death or MI in patients with ST segment elevation myocardial infarction (STEMI) is unclear. AIM: To investigate the role of MPO as a predictor of death or MI in patients with STEMI and to compare it with N-terminal pro-B-type natriuretic peptide (NT-BNP).
METHOD: 384 post STEMI patients were studied. Patients were followed up for the combined end point of death or readmission with non-fatal MI.
RESULTS: There were 40 deaths and 37 readmissions with MI. Median MPO was raised in patients experiencing death or MI than in survivors (median (range), 50.6 (15.3-124.1) ng/ml vs 33.5 (6.6-400.2) ng/ml, p = 0.001). Using a Cox proportional hazards model, log median MPO (HR 6.91, 95% CI 1.79 to 26.73, p = 0.005) and log median NT-BNP (HR 4.21, 95% CI 1.53 to 11.58, p = 0.005) independently predicted death or non-fatal MI. MPO had predictive power in both below and above median NT-BNP levels (log rank 5.60, p = 0.020 and log rank 5.12, p = 0.024, respectively). The receiver-operating curve for median NT-BNP yielded an area under the curve (AUC) of 0.72 (95% CI 0.65 to 0.79, p<0.001); for median MPO, the AUC was 0.62 (95% CI 0.55 to 0.69, p = 0.001). The logistic model combining the two markers yielded an AUC of 0.76 (95% CI 0.69 to 0.82, p<0.001).
CONCLUSION: MPO and NT-BNP may be useful tools for risk stratification of all acute coronary syndromes, including patients with STEMI at higher risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17194712      PMCID: PMC1994475          DOI: 10.1136/hrt.2006.091041

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  22 in total

1.  Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit.

Authors:  J Karl; A Borgya; A Gallusser; E Huber; K Krueger; W Rollinger; J Schenk
Journal:  Scand J Clin Lab Invest Suppl       Date:  1999

2.  Neutrophil infiltration of culprit lesions in acute coronary syndromes.

Authors:  Takahiko Naruko; Makiko Ueda; Kazuo Haze; Allard C van der Wal; Chris M van der Loos; Akira Itoh; Ryushi Komatsu; Yoshihiro Ikura; Masayuki Ogami; Yoshihisa Shimada; Shoichi Ehara; Minoru Yoshiyama; Kazuhide Takeuchi; Junichi Yoshikawa; Anton E Becker
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

3.  N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes.

Authors:  Torbjørn Omland; Anita Persson; Leong Ng; Russel O'Brien; Thomas Karlsson; Johan Herlitz; Marianne Hartford; Kenneth Caidahl
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

4.  Association between myeloperoxidase levels and risk of coronary artery disease.

Authors:  R Zhang; M L Brennan; X Fu; R J Aviles; G L Pearce; M S Penn; E J Topol; D L Sprecher; S L Hazen
Journal:  JAMA       Date:  2001-11-07       Impact factor: 56.272

5.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Authors:  J S Alpert; K Thygesen; E Antman; J P Bassand
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

6.  Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

Authors:  Marc S Sabatine; David A Morrow; James A de Lemos; C Michael Gibson; Sabina A Murphy; Nader Rifai; Carolyn McCabe; Elliott M Antman; Christopher P Cannon; Eugene Braunwald
Journal:  Circulation       Date:  2002-04-16       Impact factor: 29.690

Review 7.  Inflammation and atherosclerosis.

Authors:  Peter Libby; Paul M Ridker; Attilio Maseri
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

8.  Prognosis after acute myocardial infarction continues to improve in the reperfusion era in the community of Göteborg.

Authors:  Johan Herlitz; Mikael Dellborg; Björn W Karlson; Thomas Karlsson
Journal:  Am Heart J       Date:  2002-07       Impact factor: 4.749

9.  Widespread coronary inflammation in unstable angina.

Authors:  Antonino Buffon; Luigi M Biasucci; Giovanna Liuzzo; Giuseppe D'Onofrio; Filippo Crea; Attilio Maseri
Journal:  N Engl J Med       Date:  2002-07-04       Impact factor: 91.245

10.  Myeloperoxidase, a leukocyte-derived vascular NO oxidase.

Authors:  Jason P Eiserich; Stephan Baldus; Marie-Luise Brennan; Wenxin Ma; Chunxiang Zhang; Albert Tousson; Laura Castro; Aldons J Lusis; William M Nauseef; C Roger White; Bruce A Freeman
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

View more
  19 in total

1.  Sorting through new biomarkers.

Authors:  Frances O Wood; James A de Lemos
Journal:  Curr Cardiol Rep       Date:  2008-07       Impact factor: 2.931

2.  Cardiac myeloperoxidase activity is elevated in hypertensive pregnant rats.

Authors:  Ming-Lin Zhu; Jin-Ping Zhao; Ning Cui; Victor H Gonçalves-Rizzi; Jose S Possomato-Vieira; Regina A Nascimento; Carlos A Dias-Junior
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

3.  Diagnostic markers of acute myocardial infarction.

Authors:  Sabesan Mythili; Narasimhan Malathi
Journal:  Biomed Rep       Date:  2015-07-29

Review 4.  Reactive oxygen species in cardiovascular disease.

Authors:  Koichi Sugamura; John F Keaney
Journal:  Free Radic Biol Med       Date:  2011-05-15       Impact factor: 7.376

5.  A Synergistic Role of Myeloperoxidase and High Sensitivity Troponin T in the Early Diagnosis of Acute Coronary Syndrome.

Authors:  Mihir D Mehta; Simbita A Marwah; S Ghosh; Hitesh Shah; Amit Trivedi; N Haridas
Journal:  Indian J Clin Biochem       Date:  2015-03-14

Review 6.  Biomarkers in acute myocardial infarction.

Authors:  Daniel Chan; Leong L Ng
Journal:  BMC Med       Date:  2010-06-07       Impact factor: 8.775

Review 7.  Leukotrienes in atherosclerosis: new target insights and future therapy perspectives.

Authors:  Graziano Riccioni; Alessandra Zanasi; Nicola Vitulano; Barbara Mancini; Nicolantonio D'Orazio
Journal:  Mediators Inflamm       Date:  2010-01-26       Impact factor: 4.711

8.  Proteinase 3 and prognosis of patients with acute myocardial infarction.

Authors:  Leong L Ng; Sohail Q Khan; Hafid Narayan; Paulene Quinn; Iain B Squire; Joan E Davies
Journal:  Clin Sci (Lond)       Date:  2011-03       Impact factor: 6.124

Review 9.  Myeloperoxidase, modified lipoproteins, and atherogenesis.

Authors:  Stephen J Nicholls; Stanley L Hazen
Journal:  J Lipid Res       Date:  2008-12-16       Impact factor: 5.922

10.  Increased myeloperoxidase in the placenta and circulation of women with preeclampsia.

Authors:  Robin E Gandley; Jennifer Rohland; Yan Zhou; Eiji Shibata; Gail F Harger; Augustine Rajakumar; Valerian E Kagan; Nina Markovic; Carl A Hubel
Journal:  Hypertension       Date:  2008-06-30       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.